Enhancing Patient Care In The UK Through Recognition Routes
The medicines and healthcare products regulatory agency has gone on to announce that the new global regulatory recognition routes for drugs will be established...
Battling Global Medicine Shortages With EMA Recommendations
The European Medicines Agency has published recommendations to tackle medicine shortages and their associated repercussions. These recommendations emphasize the importance of ensuring the availability...
Machine Learning – A Game-Changer In The Pharma Industry
Machine learning, when it comes to the pharma sector, had a value of almost $1.2 billion in 2021, and it is anticipated to touch...
Impact of AI On The Pharmaceutical Industry Sparks Debates
Artificial Intelligence remains a hot topic in the pharma spectrum, and the current ChatGPT wave has begun many more conversations. As of now, there...
Advancing Pharma Logistics – Smart Contracts And Blockchain
Researchers from Sweden have identified the advantages of employing smart contracts on blockchain platforms within the pharmaceutical supply chain to combat counterfeit drugs. Despite...
Switzerland Emerges As The Headquarters For European Biotech
Analysis shows Switzerland has become the chosen headquarters for 20 per cent of European biotech companies. Out of a total of 265 companies that...
Genomics Market Growth In India To Accelerate Affordability
The Indian genomics market is projected to grow by 18% in the next five years, driven by the decreasing costs of tests and increased...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...